Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 in Human Prostate Carcinoma Cells
Open Access
- 1 April 1998
- journal article
- Published by Elsevier BV
- Vol. 273 (17), 10618-10623
- https://doi.org/10.1074/jbc.273.17.10618
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expressionNature Genetics, 1997
- The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic CellsPublished by Elsevier BV ,1996
- Mitosis in transitionCell, 1994
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- G1 phase progression: Cycling on cueCell, 1994
- Cancer Therapy Meets p53New England Journal of Medicine, 1994
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- Regulation of the mevalonate pathwayNature, 1990
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.JCI Insight, 1985